A New Type of Mucolipidosis with β-Galactosidase Deficiency and Glycopeptiduria

Tadao Orii, Ryoji Minami, Kazuko Sukegawa, +5

The Tohoku Journal of Experimental Medicine

Renal Bone MarrowUrologyNew TypeIga GlomerulonephritisImmunology +9

Congenital lysinuria: A new inherited transport disorder of dibasic amino acids

Kazuhiko Oyanagi, Ryoichi Miura, Toyoshige Yamanouchi

The Journal of Pediatrics

Congenital LysinuriaUrologyBiochemistryDibasic Amino AcidsInherited Metabolic Disease +2

Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice

Yuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, +20

Cancers

The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma

Peiyi Zhang, Atsushi Ono, Yasutoshi Fujii, +24

International Journal of Cancer

ImmunologyBiological MicroenvironmentsPathologyDistinct Vascular PatternImmunosuppressive Tumor Microenvironment +14

Clinical and Epidemiological Studies on an Outbreak of Aseptic Meningitis Caused by Coxsackie B5 and A9 Viruses in Aomori in 1961

Tooru Nakao, Toshio Nitta, Ryoichi Miura, +4

The Tohoku Journal of Experimental Medicine

Aomori CityCoxsackie B5Virus EpidemiologyPathogenesisEmergent Virus +13

ECHO Virus Type 22 Infection in a Premature Infant

Tooru Nakao, Ryoichi Miura, Mitsutake Sato

The Tohoku Journal of Experimental Medicine

Diagnostic VirologyPremature InfantsViral DiagnosticsPathogenesisEmergent Virus +9

Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets

Masashi Fujita, Mei-Ju May Chen, Doris R. Siwak, +17

Nature Communications

Endoscopic submucosal dissection for early esophageal neoplasms using the stag beetle knife

Toshio Kuwai, Toshiki Yamaguchi, Hiroki Imagawa, +10

World Journal of Gastroenterology

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

Yuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, +19

Liver Cancer

Real-world efficacy and safety of durvalumab–tremelimumab as second-line systemic therapy after atezolizumab–bevacizumab in unresectable hepatocellular carcinoma

Ryoichi Miura, Atsushi Ono, Shigeki Yano, +13

Medicine